Alto Neuroscience, Inc. (ANRO) — Financial statements
Income statement, balance sheet, and cash flow for Alto Neuroscience, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.21 | |
| Cost of Revenue | 0.66↑31.7% | 0.50 | 0.00↓100.0% | 0.34↑135.9% | 0.15 | |
| Gross Profit | -0.66↓31.7% | -0.50 | 0.00↑100.0% | -0.34↓626.2% | 0.07 | |
| Operating Expenses | ||||||
| R&D Expenses | 46↓2.9% | 47↑55.1% | 30↑27.9% | 24↑183.0% | 8 | |
| General & Administrative Expenses | 21↓4.0% | 22↑187.5% | 8↑36.6% | 6↑41.3% | 4 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00↑100.0% | -0.34↓135.9% | -0.15 | |
| SG&A Expenses | 21↓4.0% | 22↑187.5% | 8↑45.6% | 5↑37.6% | 4 | |
| Other Expenses | -0.66↓31.7% | -0.50 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 66↓3.5% | 68↑80.1% | 38↑31.1% | 29↑138.0% | 12 | |
| Total Costs & Expenses | 66↓3.3% | 69↑81.5% | 38↑29.5% | 29↑138.0% | 12 | |
| Operating Results | ||||||
| Operating Income | -66↑3.3% | -69↓81.5% | -38↓29.5% | -29↓142.1% | -12 | |
| Depreciation & Amortization | 0.66↑111.4% | -6↓1656.0% | 0.37↑9.1% | 0.34↑135.9% | 0.15 | |
| EBITDA | -66↑4.2% | -69↓98.5% | -35↓26.3% | -27↓202.7% | -9 | |
| EBIT | -66↓5.7% | -63↓79.8% | -35↓26.1% | -28↓201.6% | -9 | |
| Interest & Other Income | ||||||
| Net Interest Income | 4↓59.6% | 10↑944.5% | 0.98↑758.8% | 0.11↑5600.0% | 0.00 | |
| Interest Income | 7↓25.4% | 9↑276.8% | 2↑1960.5% | 0.11↑5600.0% | 0.00 | |
| Interest Expense | 2↑279.6% | -1↓200.4% | 1 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -6↓101.9% | -3↓93.9% | -1↑48.3% | -3 | |
| Other Income / Expenses | 3↓56.5% | 7↑377.3% | 2↑1.5% | 1↓48.3% | 3 | |
| Income Before Tax | -63↓2.9% | -61↓69.2% | -36↓31.0% | -28↓201.6% | -9 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -63↓2.9% | -61↓69.2% | -36↓31.0% | -28↓201.6% | -9 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -63↓2.9% | -61↓69.2% | -36↓31.0% | -28↓201.6% | -9 | |
| Bottom-Line Net Income | -63↓2.9% | -61↓69.2% | -36↓31.0% | -28↓201.6% | -9 | |
| EPS (Basic) | -2.19↑12.4% | -2.50↓85.2% | -1.35↓25.0% | -1.08↓200.0% | -0.36 | |
| EPS (Diluted) | -2.19↑12.4% | -2.50↓85.2% | -1.35↓25.0% | -1.08↓200.0% | -0.36 | |
| Weighted Average Shares | 29↑17.3% | 25↓8.5% | 27↑5.1% | 26↑0.0% | 26 | |
| Weighted Average Diluted Shares | 29↑17.3% | 25↓8.5% | 27↑5.1% | 26↑0.0% | 26 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.